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ABSTRACT
OBJECTIVE: To analyze cervical and breast cancer mortality in Brazil 
according to socioeconomic and welfare indicators.
METHODS: Data on breast and cervical cancer mortality covering a 30-year 
period (1980-2010) were analyzed. The data were obtained from the National 
Mortality Database, population data from the Brazilian Institute of Geography 
and Statistics database, and socioeconomic and welfare information from the 
Institute of Applied Economic Research. Moving averages were calculated, 
disaggregated by capital city and municipality. The annual percent change 
in mortality rates was estimated by segmented linear regression using the 
joinpoint method. Pearson’s correlation coefficients were conducted between 
average mortality rate at the end of the three-year period and selected 
indicators in the state capital and each Brazilian state.
RESULTS: There was a decline in cervical cancer mortality rates throughout 
the period studied, except in municipalities outside of the capitals in the North 
and Northeast. There was a decrease in breast cancer mortality in the capitals 
from the end of the 1990s onwards. Favorable socioeconomic indicators were 
inversely correlated with cervical cancer mortality. A strong direct correlation 
was found with favorable indicators and an inverse correlation with fertility 
rate and breast cancer mortality in inner cities.
CONCLUSIONS: There is an ongoing dynamic process of increased risk of 
cervical and breast cancer and attenuation of mortality because of increased, 
albeit unequal, access to and provision of screening, diagnosis and treatment. 
DESCRIPTORS: Breast Neoplasms, mortality. Uterine Cervical 
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Breast and cervical cancer are the most common malignant 
neoplasms in women worldwide. Breast cancer, together 
with lung and colorectal cancer, are among the most 
common types in high income countries, while uterine 
cancer exceeds other types in low income countries.6
Increased incidence of breast cancer in various countries 
can be partially explained by demographic and lifestyle 
changes affecting reproductive factors, such as delayed 
first pregnancy, having fewer children and shorter duration 
of breastfeeding.17 Over the last few decades, mortality 
has declined in developed countries such as the USA, the 
United Kingdom, France and Australia. The fall in inci-
dence in the USA from the year 2000 onwards is attributed 
to the reduction in hormone replacement therapy and the 
RESUMO
OBJETIVO: Analisar a evolução da mortalidade por câncer do colo uterino 
e de mama no Brasil, segundo indicadores socioeconômicos e assistenciais.
MÉTODOS: Foram analisados dados agregados de 30 anos (1980-
2010) de mortalidade por câncer de mama e colo uterino. Os dados de 
óbitos foram extraídos do Sistema de Informações sobre Mortalidade, 
os denominadores populacionais, do Instituto Brasileiro de Geografia e 
Estatística, e os indicadores socioeconômicos e assistenciais do Instituto 
de Pesquisa Econômica e Aplicada. Foram calculadas as médias móveis 
desagregadas por capitais e municípios do interior dos estados. O 
percentual de mudança anual das taxas foi estimado a partir da regressão 
linear segmentada por joinpoint. Foi feita correlação de Pearson entre as 
taxas médias trienais do final do período e os indicadores selecionados 
das capitais e de cada estado brasileiro.
RESULTADOS: Houve queda da mortalidade por câncer do colo uterino em 
todo o período, exceto em municípios das regiões Norte e Nordeste fora das 
capitais. Houve declínio na mortalidade por câncer de mama nas capitais a 
partir do final da década de 1990. Os indicadores socioeconômicos positivos 
correlacionaram-se inversamente com a mortalidade de câncer do colo uterino. 
Observou-se forte correlação direta entre indicadores positivos e inversa com 
a taxa de fecundidade e a mortalidade por câncer de mama nos municípios do 
interior dos estados.
CONCLUSÕES: Encontra-se em curso um mecanismo dinâmico entre aumento 
de risco por câncer de mama e do colo uterino com atenuação da mortalidade 
em função da expansão de oferta e acesso ao rastreamento, diagnóstico e 
tratamento, porém de forma desigual.
DESCRITORES: Neoplasias da Mama, mortalidade. Neoplasias do Colo 
do Útero, mortalidade. Acesso aos Serviços de Saúde. Estudos de Séries 
Temporais..
INTRODUCTION
decreased number of pre-clinical cases detected through 
screening, which began over 20 years ago.12
The introduction of cervical cancer screening in devel-
oped countries proved that this measure significantly 
reduces incidence of, and mortality from, this disease 
and prolongs patient survival. However, this has not 
been observed in low income countries where access 
to primary and specialized care is limited.16
In Brazil, the Sistema de Informações sobre Mortalidade 
(SIM – National Mortality Database) recorded 12,705 
deaths from breast cancer and 4,986 from cervical 
cancer in 2010, together accounting for 21.4% of 
cancer deaths in that year.a The indicators would be 
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greater than those officially released if corrections 
referring to “undefined” causes and cases classified 
as “non-specified area of uterus” were made. Using 
these data to project expected number of new cases in 
this country, more than 50,000 women would be diag-
nosed with breast cancer annually, and around 20,000 
with cervical cancer.
Analysis of temporal trends in mortality between 1980 
and 2006 indicate that there are differentiated patterns to 
these cancers in Brazil, with a fall in cervical cancer and 
an increase in breast cancer.4 When data for state capi-
tals and other municipalities are disaggregated, these 
trends are shown to have different inclinations. The 
decrease in cervical cancer in women in the Southeast, 
South and Central-West is clear. However, in the North 
and Northeast, such a fall is only apparent in the state 
capitals and rates in residents in the interior show statis-
tically significant increases.
During the period, increases in mortality from breast 
cancer were verified in all five regions of Brazil, although 
a declining trend in the coefficients was observed in state 
capitals from the end of the 1990s onwards.
The great challenge for middle and low income coun-
tries is to ensure strategies that enable early diagnosis 
of these two types of cancer and to reduce trends in 
mortality. It would be possible to reduce cervical cancer 
incidence if all women with premalignant lesions had 
access to appropriate treatment.
It is essential that trends in incidence and mortality are 
monitored in order to evaluate the results of screening 
strategies which have been shown to be effective in 
other countries.
The aim of this study was to analyze the evolution of 
breast and cervical cancer mortality in state capitals and 
other Brazilian municipalities, according to socioeco-
nomic and health care indicators.
METHODS
This is a study of breast and cervical cancer mortality 
in state capitals and other municipalities in the five 
Brazilian regions, using aggregated time series data 
from a 30-year-period (1980-2010). The data on 
deaths were obtained from the SIM, population data 
from Brazilian Institute of Geography and Statistics 
(IBGE) demographic censusesa and socioeconomic 
and health care indicators from the Institute of Applied 
Economic Research (IPEA).b Population data between 
the censuses were estimated using linear interpolation.
Between 1980 and 1995, the deaths included were 
those classified using the Manual of the International 
Statistical Classification of Diseases, Injuries, and 
Causes of death (ICD-9); and those occurring between 
1996 and 2010, classified using the International 
Statistical Classification of Diseases and Related 
Health Problems (ICD-10). Breast cancer and 
cervical cancer correspond to codes: 174(ICD-9) and 
C50(ICD-10), 180(ICD-9) and C53(ICD-10), respec-
tively, reported to the SIM and classified under these 
codes after correction.
Correction for breast and cervical cancer deaths was 
conducted by proportionally redistributing 50.0% of 
deaths classified as “undefined” (codes: 780-799 of the 
ICD-9 and R00-R99 of the ICD-10), using the World 
Health Organization (WHO) proportional redistribution 
methodology.c Correction factors were calculated for 
each five-year-period, age and sex for capital and inte-
rior of each state. Cervical cancer deaths were corrected 
by redistributing all deaths classified as non-specified 
uterine cancer (codes 179 of the ICD-9 and C55 of the 
ICD-10), maintaining the same proportion of deaths 
from cervical and uterine cancer.9
Average breast and cervical cancer mortality rates 
(to the order of three) were calculated and standard-
ized, corrected for age group using the direct method, 
taking the world population standard as a reference.d 
The time trend was evaluated using joinpoint regres-
sion, version 3.4.3. Year of death was the independent 
variable and mortality rates the dependent variable, 
according to the following groupings: large regions, 
state capitals and other municipalities (interior). The 
models were adjusted assuming a different number of 
joinpoints, from zero (trend represented by one single 
segment of the line) to three; considering changes in 
the rates over time. Annual percentage changes (APC) 
were calculated for each type of cancer, period and 
geographic area.
The adjusted and corrected mean rates for the last 
three-year-period (2008 to 2010) were correlated 
with socioeconomic and health care indicators avail-
able for 2000 in the IPEA for state capitals and states. 
The indicators were classed as positive or negative. 
The positive corresponded to better living condi-
tions: number of doctors/1,000 inhabitants, except 
for Teresina, PI, where this indicator was not avail-
able; proportion of individuals aged ≥ 25 with at 
least 11 years of schooling; proportion of individ-
uals living in households with electricity; human 
development index (HDI); proportion of individuals 
living in households with plumbing. The negative 
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indicators corresponded to worse conditions: propor-
tion of population aged ≥ 25 who are illiterate; 
fertility rate; proportion of individuals living below 
the poverty line, i.e., on under half a minimum wage 
per capita; mortality rate in children < 5/1,000 live 
births; percentage of households headed by women, 
without partner and with children < 15.
Pearson’s correlation coefficients were calculated 
between the three-year average rates (2008-2010) in 
the Federal District and the state capitals and other 
municipalities in each state and the indicators in the 
capitals and states, respectively, using the R statistic 
program (version 2.7.1). Values between 0.70 and 1 
were deemed strong correlation, moderate 0.30 to 0.69 
and weak 0 to 0.29.
The research was approved by the Research Ethics 
Committee of the Instituto de Medicina Social, 
Universidade do Estado do Rio de Janeiro (Process 
CAAE 0027.0.259.000-09, 8/12/2009), and followed 
ethical standards.
RESULTS
In the 1980s, the magnitude of breast cancer mortality 
in Brazilian women was similar to that of cervical 
cancer. However, breast cancer always weighed 
more heavily in state capitals (Figure 1). Patterns in 
mortality rates for the two types of cancer in Brazil 
differed over the 30 years: a clear fall in cervical 
cancer, more pronounced in state capitals, and an 
increase in breast cancer. From the end of the 1990s, 
number of deaths from this cancer began to decrease 
in women living in the state capitals.
The same comparison with data disaggregated by 
region shows a difference in magnitude and trends of 
mortality for these two types of cancer (Figure 2). In 
the North, cervical cancer mortality was higher than 
that of breast cancer throughout the period, and there 
was a fall in deaths among women living in the state 
capitals and an increase in those in the interior. Breast 
cancer increased evenly in all municipalities. This 
profile differed in the Northeast, where breast cancer 
mortality rates exceeded those of cervical cancer at the 
end of the period, with a marked increase in women 
living in the interior. Cervical cancer mortality coef-
ficients in the South and Southeast were lower than 
those of breast cancer and there was a clear trend of 
decline in the female population as a whole. A decline 
in deaths from breast cancer was noted in the state 
capitals of the South from the mid-1990s onwards, 
and in the Southeast from the end of that decade. In 
the Central-West, throughout the period, there was an 
increase in breast cancer mortality and a fall in cervical 
cancer mortality. The speed of the advance of breast 
cancer among women living outside the state capitals 
was considerable.
Regression analysis using joinpoint showed a signifi-
cantly statistic drop in mortality rates from cervical 
cancer in the state capitals and other municipalities in 
the Southeast, South and Central-West (Table 1). In 
the North and Northeast, there was a fall in the state 
capitals and an increase in the interior. The largest 
drop was observed in state capitals in the Northeast 
(APC -3.3; 95%CI -3.5;-3.1).
The patterns of breast cancer mortality trends differed 
between the regions and between the state capitals and 
other municipalities (Table 2). There was an overall 
increase in rates in the first observation period, with 
the exception of in the interior of the North. Mortality 
rates for this cancer continued to grow in the interior 
of the North and Northeast and in the state capitals in 
the North. However, the rates began to fall in other 
regions, both in the state capitals and outside of them. 
The greatest growth was observed in the North, in 
municipalities in the interior, between 1999 and 2010 
(APC = 5.0; 95%CI 3.3;6.8) and in the interior of the 
Northeast (APC = 4.9; 95%CI 4.4;5.5). The greatest 
annual drop was observed between 1997 and 2002 in 
the Southeast (APC = -2.8; 95%CI -3.7;-1.9).
Figure 1. Breast and cervical cancer mortalitya. Brazil, overall and by state capitals and other municipalities, 1980 to 2010.
a per 100,000 inhabitants, adjusted for the population of the demographic census – Brazil 2010 and corrected (see Methods).
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Figure 2. Breast and cervical cancer mortality.a Brazil, overall and by state capitals and other municipalities, 1980 to 2010.
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Correlation analysis was conducted between some 
socioeconomic and health care positive and negative 
indicators (doctors/1,000 inhabitants) and mortality 
rates in residents in the state capitals or other munici-
palities in the states. A moderate direct relationship 
between three positive indicators and an inverse rela-
tionship, also moderate, were found with breast cancer. 
In the interior, there were strong correlations with 
almost all the positive indicators and, of the negative 
indicators, there was a strong correlation with fertility 
(r = -0.92; p < 0.0001) and the percentage of female 
head of household, single and with children under 15 
(r = -0.82; p < 0.0001), with moderate correlation with 
the other three (Table 3).
Mortality indicators behaved differently for cervical 
cancer in the state capitals: of the five positive indica-
tors, three were negatively correlated, and of the five 
negatives, three correlated positively. The indicators 
analyzed do not show correlation with cervical cancer 
mortality rates in the interior, with the exception of 
percentage of individuals living below the poverty line 
(r = 0.46; p = 0.017).
DISCUSSION
The results suggest there is a dynamic mechanism 
between determining risk exposures in the appear-
ance of breast and cervical cancer. At the same time, 
Table 1. Joinpoint regression analysis of cervical cancer mortality trends. State capitals and other municipalities in the Brazilian 




North Capitals 1980 to 2010 -1.8 -2.0;-1.6
Other municipalities 1980 to 2010 1.7 1.2;2.2
Northeast Capitals 1980 to 2010 -3.3 -3.5;-3.1
Other municipalities 1980 to 2010 1.0 0.8;1.3
Southeast Capitals 1980 to 2010 -1.9 -2.2;-1.7
Other municipalities 1980 to 2010 -2.2 -2.5;-2.0
South Capitals 1980 to 2010 -2.7 -3.1;-2.2
Other municipalities 1980 to 2010 -1.8 -2.1;-1.4
Central-West Capitals 1980 to 2010 -3.1 -3.4;-2.8
Other municipalities 1980 to 2010 -1.1 -1.6;-0.6
Brazil Capitals 1980 to 2010 -2.2 -2.4;-2.0
Other municipalities 1980 to 2010 -1.0 -1.2;-0.9
APC: annual percentage change.
Table 2. Joinpoint regression analysis of breast cancer mortality trends. State capitals and other municipalities in the Brazilian 
regions, 1980 to 2010.
Region Municipalities 
Trend 1 Trend 2 Trend 3
Years APC 95%CI Years APC 95%CI Years APC 95%CI
North Capitals 1980 to 1984 -2.1 -7.3;3.4 1984 to 2010 1.0 0.6;1.3 – – –
Other municipalities 1980 to 1999 3.1 2.4;3.9 1999 to 2010 5.0 3.3;6.8 – – –
Northeast Capitals 1980 to 1992 0.4 -0.3;1.1 1992 to 2010 -0.5 -0.8;-0.1 – – –
Other municipalities 1980 to 1997 1.5 1.2;1.9 1997 to 2010 4.9 4.4;5.5 – – –
Southeast Capitals 1980 to 1997 0.9 0.8;1.0 1997 to 2002 -2.8 -3.7;-1.9 2002 to 2010 -0.6 -0.9;-0.2
Other municipalities 1980 to 2010 0.6 0.4;0.8 – – – – – –
South Capitals 1980 to 1991 1.6 1.1;2.2 1991 to 2010 -1.3 -1.5;-1.1 – – –
Other municipalities 1980 to 1993 1.9 1.6;2.2 1993 to 2010 -0.2 -0.4;0.0 – – –
Central-West Capitals 1980 to 1996 1.4 1.0;1.8 1996 to 2010 -0.9 -1.4;-0.4 – – –
Other municipalities 1980 to 2010 2.4 2.0;2.8 – – – – – –
Brazil Capitals 1980 to 1997 0.7 0.6;0.8 1997 to 2003 -2.6 -3.2;-1.9 2003 to 2010 0.0 -0.4;0.5
Other municipalities 1980 to 2010 1.1 1.0;1.2 – – – – – –
APC: annual percentage change
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mortality is attenuated due to better access to diagnostic 
and treatment measures. The fall in cervical cancer 
mortality occurred in women all over the Southeast 
and South, the most developed regions of the country, 
whereas for women in the North and Northeast it only 
occurred in the state capitals. Likewise, deaths from 
breast cancer began to decrease in women living in 
the state capitals in the South and Southeast from the 
mid-1990s onwards.
Declining cervical cancer mortality may reflect the 
protection provided by the Pap smear test. This was 
not observed in the interior of the North and Northeast.
Breast cancer mortality increased, partly, due to 
increased incidence of the disease. This may be 
explained by the increasing adoption of urban life-
styles among women, which directly affects the degree 
of exposure to reproductive factors. The large annual 
increase in mortality rates in the North and Northeast 
suggests that changes in reproductive and sexual 
behavior, initiated in large urban centers, were rapidly 
adopted by women in other municipalities, even those 
in low income areas. On the other hand, the reversal in 
mortality rates that began in the capitals was possible 
due to access to diagnostic and treatment measures, 
more effective at the initial stages of the disease.
Brazilian studies have shown overall rates of HPV infec-
tion varying between 13.7% and 54.3%.3 The number of 
women infected is growing in all regions of the country, 
probably accompanying early onset of sexual activity.e
This is a malignant neoplasm that can be prevented by 
screening for intraepithelial neoplastic lesions. Thus, the 
fall in mortality that began in the more developed regions 
of Brazil, moving thence to the state capitals in other 
regions, indicates certain success in screening interven-
tions. The increased availability of the Papanicolaou test 
may have partially reversed the risk of death in women 
with access to preventative measures.
Actions to control cervical cancer began in the 1980s. 
They intensified between 1999 and 2002, period in 
which two campaigns of the Viva Mulher program were 
conducted,f leading to a substantial increase in provi-
sion of the Papanicolaou test in all regions of Brazil.g
However, a fall in mortality from this cancer had been 
detected in several states even before these initiative 
Table 3. Correlation between breast and cervical cancer mortality rates and selected socioeconomic and health care indicators. 
Capitals and other municipalities in Brazil, 2008 to 2010.
Breast cancer Cervical cancer
Indicators Capitals Other municipalities Capitals Other municipalities
Correlation p Correlation p Correlation p Correlation p
Positive
Human development index (HDI) 0.32 0.0990 0.58 0.0020 -0.38 0.0502 -0.38 0.0585
Doctors (per thousand inhabitants)a  0.61 0.0008 0.81 < 0.0001 -0.51 0.0084 -0.29 0.1581
% individuals aged ≤ 25 with more 
than 11 years of schooling
0.51 0.0063 0.78 < 0.0001 -0.57 0.0018 -0.37 0.0636
% individuals in households with 
electricity 
0.36 0.0635 0.71 < 0.0001 -0.17 0.3828 -0.36 0.0745
% individuals in households with 
plumbing
0.53 0.0047 0.82 < 0.0001 -0.40 0.0404 -0.36 0.0689
Negative
% population aged ≤ 25 who are 
illiterate 
-0.22 0.2764 -0.47 0.0155 0.18 0.3588 0.27 0.1893
Fertility rate (%) -0.59 0.0013 -0.92 < 0.0001 0.52 0.0056 0.35 0.0754
% individuals living below the 
poverty line
-0.26 0.1878 -0.62 0.0007 0.45 0.0198 0.46 0.0173
Mortality rate in children < 5 per 
1,000 LB
-0.16 0.4283 -0.40 0.0429 0.36 0.0613 0.39 0.0508
% female head of household, 
single and with children aged ≤ 15 
-0.44 0.0223 -0.82 < 0.0001 0.33 0.0895 0.24 0.2421
LB: live births
a Except for Teresina, PI, as the indicator was not available.
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commenced. Decreases in cervical cancer deaths had 
been recorded in the municipality of Sao Paulo between 
1980 and 1999,8 between 1984 and 20032 and between 
1987 and 1998 in the municipalities of Campinas, 
Piracicaba and Sao Joao da Boa Vista,18 all in the 
state of Sao Paulo. Similar declines were identified in 
Paraná5 and in Minas Gerais between 1980 and 2005.1 
Actions to organize screening for the disease at a state 
and local level, in the case of Sao Paulo and Paraná, 
may have encouraged the start of the fall in mortality 
in the South and Southeast.
Data from household surveys confirm an increase in 
preventative examinations that became part of national 
policy for controlling cancer over the last decade. Data 
from the Pesquisa Nacional de Amostras de Domicílio 
(PNAD – National Household Survey) estimated 82.6% 
coverage of preventative gynecological examinations 
in women aged 25 to 59 in 2003.h This estimate was 
87.1% in 2008, an increase across all income classes, 
although of a more marked nature among the poorest.
Correlation analysis confirms what has been shown 
in the literature.4,6,9 Cervical cancer mortality coeffi-
cients in the state capitals are inversely correlated with 
indicators of better socioeconomic status and directly 
correlated with negative indicators. This indicates that 
it is more difficult for women living in state capitals to 
have cervical cancer screening tests done. In the inte-
rior, only the percentage of individuals living below 
the poverty line was related to increased mortality 
from this type of cancer. Are we faced with a situation 
in which women, outside of urban centers, who do not 
undergo cervical cancer screening are living in worse 
conditions? Is inequality in access concentrated in those 
who live in extreme poverty, while barriers also affect 
others on low incomes in the capitals?
Breast cancer mortality rates rose in Brazil according 
to increased positive socioeconomic indicators and 
decreased as negative indicators, such as fertility rates, 
increased. This relationship appears better in the inte-
rior, suggesting that rates outside of the capitals were 
not attenuated by women diagnosed with the disease 
receiving treatment.
The main breast cancer risk factors are related to sexual 
and reproductive history.14 The fall in mortality in devel-
oped countries is attributed to improved survival due to 
awareness, early detection and improved treatment.11 
The demographic transition taking place in Brazil, with 
falling birth rates and having children later,i weighs 
significantly in increased incidence of the disease. 
Mortality accompanied this increase, which occurred 
homogeneously in women in different regions of the 
country. Lifestyle changes appear to be reflected in 
reproductive factors and rapidly affect women in the 
interior. Decreased breast cancer deaths in the South 
and Southeast may show the results of better access to 
mammography and specialist treatment services, bene-
fitting women diagnosed when the disease is in its early 
stages. In Brazil, this phenomenon is more recent than 
the Pap smear examination.
Although some breast cancer screening proposals were 
included in the intensification stage of the Viva Mulher 
program in 2002, it was in 2004 that the Ministry of 
Health launched the breast cancer control consensus, 
recommending that women aged between 50 and 69 
have a mammogram every two years.j
PNAD datag from 2003 and 2008 confirm increased 
numbers of mammograms in women in the Ministry of 
Health target age group (50 to 69 years old), especially 
among those on higher incomes and with higher levels 
of education and who have health insurance. Although 
the percentage of women between 50 and 69 who 
reported having a mammogram increased from 54.6% 
in 2003 to 71.5% in 2008, among those with household 
income > 5 minimum wages, the increase was from 
76.6% to 80.7%. These percentages were 20.2% in 2003 
and 29.1% in households on an income of < 25.0% 
minimum wage in 2008, demonstrating considerable 
inequality in access by socioeconomic level. Residents 
in metropolitan areas are three times more likely to have 
the examination than those in other areas.15
The study was based on SIM data, which could pose 
a significant limitation due to regional differences in 
the coverage, completeness and quality of the informa-
tion.7 However, previous studies indicate that cancer 
deaths are better recorded, although some of them may 
be included in the undefined causes categories, which 
have decreased markedly in this country.13 The deci-
sion to correct 50.0% of undefined deaths, together 
with moving averages and joinpoint regression meant 
that the trends in cancer mortality coefficients could 
be approximated.
The effect of screening on reducing breast cancer 
mortality is lower than that which occurred with 
cervical cancer. Recent studies indicate that the impact 
of mammography screening on mortality is less than 
hoped10 and that the large reduction in mortality in 
developed countries is attributable to recent advances 
in treatment.11 This reality is compatible with countries 
h Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios: um panorama da saúde no Brasil: acesso e 
utilização dos serviços, condições de saúde e fatores de risco e proteção à saúde - PNAD 2008. Rio de Janeiro; 2010. 
i Minamiguchi MM. Segunda transição demográfica: o que se pode dizer da situação brasileira? [dissertação de mestrado]. Rio de Janeiro: 
Escola Nacional de Ciências Estatísticas; 2011.
j Instituto Nacional de Câncer, Coordenação de Prevenção e Vigilância. Controle do câncer de mama no Brasil: documento de consenso. Rio 
de Janeiro; 2004 [cited 2012 Dec]. Available from: http://www1.inca.gov.br/publicacoes/Consensointegra.pdf
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in which it is not so difficult to access cancer diagnosis 
and treatment services. The obstacles are enormous 
for Brazil’s socioeconomically deprived population. 
Urgent measures are needed to guarantee that all 
women have access to the best diagnosis and treat-
ment available.
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